Published online July 2, 2007
PEDIATRICS Vol. 120 No. 1 July 2007, pp. 171-172 (doi:10.1542/peds.2007-0602)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keogh, J. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Keogh, J. M.
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

COMMENTARY

Determinants of Outcome After Head Cooling for Neonatal Encephalopathy

John M. Keogh, FRANZCOG

Obstetrics and Gynaecology, Hornsby Hospital, Hornsby, New South Wales, Australia

Abbreviations: HIE, hypoxic-ischemic encephalopathy

The first 20% of the full text of this article appears below.

If the inhabitants of Olympus were to set 10 tasks for Hercules in perinatology, then the prevention and limitation of neurologic injury would be high on the list, along with the prevention of preeclampsia, prematurity, postpartum hemorrhage, and the impact of poverty on pregnancy outcome.

The Cool Cap (Olympic Medical, Seattle, WA)1 Trial is a step along this path. The role of this technology is as-yet uncertain, its long-term benefits are unclear, and its safety profile is still incompletely defined. However, given the frequency of adverse outcomes in this group (>60% in the whole cohort), the promising outcomes of the original randomized trials strongly suggest that cooling will be an important part of our armamentarium in the years ahead.

The latest article2 from the group presents an exploratory posthoc analysis of the data from the Cool-Cap Trial for the purpose of hypothesis generation to inform additional studies of factors that may influence the outcome of treatment.

The original study (and, therefore, the conclusions drawn from it) was, to some extent, held hostage by the difficulties inherent in the prospective diagnosis of hypoxic-ischemic encephalopathy (HIE). This subgroup of infants with newborn encephalopathy is of particular interest because of the association with acute intrapartum problems. A pathology that is in evolution at the time of birth may be reversible. Unfortunately, the criteria used to demonstrate a hypoxic-ischemic etiology as set out in the study's inclusion criteria (ie, Apgar score of ≤5 at 10 minutes, need for . . . [Full Text of this Article]

Address correspondence to John M. Keogh, FRANZCOG, Obstetrics and Gynaecology, Hornsby Hospital, Palmerston Road, Hornsby, New South Wales 2077, Australia. E-mail: keoghj1@optushome.com.au


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?